Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00390637
Other study ID # DiOGenes FP6-2005-513946
Secondary ID FOOD-2004-513946
Status Completed
Phase Phase 4
First received
Last updated
Start date January 2006
Est. completion date December 2009

Study information

Verified date October 2018
Source University of Copenhagen
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Study Title: Diogenes, A randomised controlled trial comparing the effect of reduced-fat diets varying in glycaemic index (high vs. low) and protein content (high vs. normal) on bodyweight in overweight and obese subjects after an initial weight loss.


Description:

DiOGenes is a randomised controlled dietary intervention study in obese/overweight families (adults and children) in 8 different European countries, testing the efficacy and safety of diets differing in Glycaemic Index (GI) and protein content.

The 8 centres are divided into "shop centers" and "instruction centers", that provide different kind of dietary intervention and for a different length(see below):

The 2 Shop Centers (Denmark & The Netherlands):

Dietary periods and clinical examinations:

1. Clinical examination 1 with anthropometry, blood etc.

2. 8 week Low Calorie Diet (LCD) period (800-1000 kcal/day)(Adults only)

3. Clinical examination 2 with anthropometry, blood etc.

4. 6 months dietary intervention period 1 (SUPERMARKET period)(Family)

5. Clinical examination 3 with anthropometry, blood etc.

6. 6 months dietary intervention period 2 (DIETARY INSTRUCTION period)(Family).

7. Clinical examination 4 with anthropometry, blood ect.

8. 12 months free-living period with no dietary intervention. (Family)

9. Follow up (only body weight registration)

The 6 Instruction Centers (UK, Crete, Germany, Spain, Bulgaria, Czech Republic)

Dietary periods and clinical examinations:

1. Clinical examination 1 with anthropometry, blood etc.

2. 8 week Low Calorie Diet (LCD) period (800-1000 kcal/day). (Adults only)

3. Clinical examination 2 with anthropometry, blood etc.

4. 6 months dietary intervention period (DIETARY INSTRUCTION period). (Family)

5. Clinical examination 3 with anthropometry, blood etc.

6. 6 months free-living period with no dietary intervention. (Family)

7. Follow up (only body weight registration)

Note that, during the first 6 month intervention all families from the shop centers are provided all foods free of charge "SUPERMARKET PERIOD", whereas in the "Instruction Centers", the families receive dietary instruction only "Instruction Only".


Recruitment information / eligibility

Status Completed
Enrollment 1020
Est. completion date December 2009
Est. primary completion date March 2008
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 5 Years to 65 Years
Eligibility Inclusion Criteria:

- Families with healthy adults and children

Exclusion Criteria:

- Various

Study Design


Intervention

Behavioral:
High or low Glycemic Index and high or low Protein Diet


Locations

Country Name City State
Denmark Arne V. Astrup Copenhagen

Sponsors (2)

Lead Sponsor Collaborator
University of Copenhagen European Commission

Country where clinical trial is conducted

Denmark, 

References & Publications (1)

Saris WH, Harper A. DiOGenes: a multidisciplinary offensive focused on the obesity epidemic. Obes Rev. 2005 May;6(2):175-6. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other For adults: Identify traits biological that determine responses to the dietary intervention. To identify biological traits that determine the family's and individual's responses to the dietary interventions. 12 months
Other For adults: Identify psychological traits that determine responses to the dietary intervention. To identify psychological traits that determine the family's and individual's responses to the dietary interventions. 12 months
Other For adults: Identify traits gene - diet interactions that determine responses to the dietary intervention. To identify gene - diet interactions (e.g. SNP x dietary intake or copy number x dietary intake) that determine the family's and individual's responses to the dietary interventions. 12 months
Primary For adults: body weight loss maintenance The primary outcome is related to body weight loss maintenance after 6 month of intensive, homogeneous and therefore comparable dietary intervention across all 8 centres. 6 Month
Secondary For adults: change in body composition The relative loss or gain of fat mass and fat free mass 6 Month
Secondary For adults: More than 5% weight loss maintenance Achievement of 5% of body weight loss from randomization 6 month
Secondary For adults: More than 10% weight loss maintenance Achievement of 10% of body weight loss from randomization 6 month
Secondary For adults: Drop out rate Percentage drop out from randomisation to end of dietary intervention 6 month
Secondary For Adults: Change in risk factors for type-2 diabetes Change in risk factors for type-2 diabetes 6 month
Secondary For Adults: Change in risk factors for cardiovascular disease Change in risk factors for cardiovascular disease 6 month
Secondary For children: Change in body weight Change in body weight from randomization to end of intervention 6 month
Secondary For Children: Change in BMI-Z-score Change in BMI-Z-score from randomisation to end of intervention 6 month
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2

External Links